|
|
 Previous Article | Table of Contents | Next Article 
Blood, 15 August 2001, Vol. 98, No. 4, pp. 1108-1115
IMMUNOBIOLOGY
Tumor necrosis factor- induces coordinated changes in major
histocompatibility class I presentation pathway, resulting in increased
stability of class I complexes at the cell surface
Kristian Hallermalm,
Katzutake Seki,
Chenhong Wei,
Chiara Castelli,
Licia Rivoltini,
Rolf Kiessling, and
Jelena Levitskaya
From the Cancer Centrum Karolinska and the Microbiology
and Tumorbiology Center, Karolinska Institutet, Stockholm, Sweden; and
Unita Operativa Immunoterapia dei Tumori Umani, Istituto Nazionale
Tumori, Milan, Italy.
It is demonstrated that similar to interferon  (IFN-), tumor
necrosis factor- (TNF-) induces coordinated changes at different steps of the major histocompatibility complex (MHC) class I processing and presentation pathway in nonprofessional antigen-presenting cells
(APCs). TNF- up-regulates the expression of 3 catalytic immunoproteasome subunits LMP2, LMP7, and MECL-1the immunomodulatory proteasome activator PA28, the TAP1/TAP2 heterodimer, and the total
pool of MHC class I heavy chain. It was also found that in
TNF--treated cells, MHC class I molecules reconstitute more rapidly
and have an increased average half-life at the cell surface. Biochemical changes induced by TNF- in the MHC class I pathway were
translated into increased sensitivity of TNF--treated targets to
lysis by CD8+ cytotoxic T cells, demonstrating improved
presentation of at least certain endogenously processed MHC class
I-restricted peptide epitopes. Significantly, it was demonstrated that
the effects of TNF- observed in this experimental system were not
mediated through the induction of IFN-. It appears to be likely that
TNF--mediated effects on MHC class I processing and presentation do
not involve any intermediate messengers. Collectively, these data
demonstrate the existence of yet another biologic activity exerted by
TNF-, namely its capacity to act as a coordinated multi-step
modulator of the MHC class I pathway of antigen processing and
presentation. These results suggest that TNF- may be useful when a
concerted up-regulation of the MHC class I presentation machinery is
required but cannot be achieved by IFN-.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
S. Scheffler, U. Kuckelkorn, K. Egerer, T. Dorner, K. Reiter, A. Soza, G.-R. Burmester, and E. Feist
Autoimmune reactivity against the 20S-proteasome includes immunosubunits LMP2 ({beta}1i), MECL1 ({beta}2i) and LMP7 ({beta}5i)
Rheumatology,
May 1, 2008;
47(5):
622 - 626.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Hallermalm, K. Seki, A. De Geer, B. Motyka, R. C. Bleackley, M. J. Jager, C. J. Froelich, R. Kiessling, V. Levitsky, and J. Levitskaya
Modulation of the Tumor Cell Phenotype by IFN-{gamma} Results in Resistance of Uveal Melanoma Cells to Granule-Mediated Lysis by Cytotoxic Lymphocytes
J. Immunol.,
March 15, 2008;
180(6):
3766 - 3774.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Strehl, T. Joeris, M. Rieger, A. Visekruna, K. Textoris-Taube, S. H. E. Kaufmann, P.-M. Kloetzel, U. Kuckelkorn, and U. Steinhoff
Immunoproteasomes Are Essential for Clearance of Listeria monocytogenes in Nonlymphoid Tissues but Not for Induction of Bacteria-Specific CD8+ T Cells
J. Immunol.,
November 1, 2006;
177(9):
6238 - 6244.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Cangemi, B. Morandi, A. D'Agostino, C. Peri, R. Conte, G. Damonte, G. Ferlazzo, R. Biassoni, and G. Melioli
IFN-{alpha} mediates the up-regulation of HLA class I on melanoma cells without switching proteasome to immunoproteasome
Int. Immunol.,
December 1, 2003;
15(12):
1415 - 1421.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Vertuani, A. De Geer, V. Levitsky, P. Kogner, R. Kiessling, and J. Levitskaya
Retinoids Act as Multistep Modulators of the Major Histocompatibility Class I Presentation Pathway and Sensitize Neuroblastomas to Cytotoxic Lymphocytes
Cancer Res.,
November 15, 2003;
63(22):
8006 - 8013.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. J. P. Gobin, P. Biesta, and P. J. Van den Elsen
Regulation of human beta 2-microglobulin transactivation in hematopoietic cells
Blood,
April 15, 2003;
101(8):
3058 - 3064.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Cannon and J. L. Pate
Expression and Regulation of Interferon {gamma}-Inducible Proteasomal Subunits LMP7 and LMP10 in the Bovine Corpus Luteum
Biol Reprod,
April 1, 2003;
68(4):
1447 - 1454.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Lacayo, H. Sato, H. Kamiya, and M. A. McVoy
Down-regulation of surface major histocompatibility complex class I by guinea pig cytomegalovirus
J. Gen. Virol.,
January 1, 2003;
84(1):
75 - 81.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. F. Barton, M. Cruz, R. Rangwala, G. S. Deepe Jr., and J. J. Monaco
Regulation of Immunoproteasome Subunit Expression In Vivo Following Pathogenic Fungal Infection
J. Immunol.,
September 15, 2002;
169(6):
3046 - 3052.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. J. Cho, T. Hayashi, S. K. Datta, K. Takabayashi, J. H. Van Uden, A. Horner, M. Corr, and E. Raz
IFN-{alpha}{beta} Promote Priming of Antigen-Specific CD8+ and CD4+ T Lymphocytes by Immunostimulatory DNA-Based Vaccines
J. Immunol.,
May 15, 2002;
168(10):
4907 - 4913.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
